Literature DB >> 32858147

Gene-environment interaction promotes Alzheimer's risk as revealed by synergy of repeated mild traumatic brain injury and mouse App knock-in.

Marius Chiasseu1, Arman Fesharaki-Zadeh1, Takashi Saito2, Takaomi C Saido3, Stephen M Strittmatter4.   

Abstract

There is a strong unmet need for translational progress towards Alzheimer's disease (AD) modifying therapy. Unfortunately, preclinical modeling of the disease has been disappointing, relying primarily on transgenic mouse overexpression of rare dominant mutations. Clinical manifestation of AD symptoms is known to reflect interaction between environmental and genetic risks. Mild traumatic brain injury (mTBI) is an environmental risk for dementia, including Alzheimer's, but there has been limited mechanistic analysis of mTBI contribution to AD. Here, we investigate the interplay between mTBI and Aβ precursor protein gene mutation in AD pathogenesis. We employed a knock-in (KI) model of AD that expresses the Aß-containing exons from human APP bearing the Swedish and Iberian mutations, namely AppNL-F/NL-F mice. Without environmental risk, this genetic variation yields minimal mouse symptomatology. Anesthetized 4-month-old KI mice and their age-matched wild type (WT) controls were subjected to repeated mild closed head injury (rmCHI), once daily for 14 days. Anesthetized, uninjured genotype- and age-matched mice were used as sham controls. At 3- and 8-months post-injury, amyloid-β, phospho-tau and Iba1 expression in the injured KI cortices were assessed. Our data reveal that rmCHI enhances accumulation of amyloid-β and hyperphosphorylated tau inclusions, as well as neuroinflammation in AppNL-F/NL-F mice. Furthermore, novel object recognition and Morris water maze tests demonstrated that rmCHI greatly exacerbates persistent cognitive deficits in APPNL-F/NL-F mice. Therefore, study of gene-environment interaction demonstrates that combining risk factors provides a more robust model for AD, and that repeated mTBI substantially accelerates AD pathology in a genetically susceptible situation.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid-beta; Cognitive decline; Neuroinflammation; Repeated mild traumatic brain injury; Tau protein

Year:  2020        PMID: 32858147      PMCID: PMC7572902          DOI: 10.1016/j.nbd.2020.105059

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  102 in total

1.  Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.

Authors:  Hien T Tran; Frank M LaFerla; David M Holtzman; David L Brody
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

2.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

3.  Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury.

Authors:  Jian Zhang; Zhaoqian Teng; Yunping Song; Mei Hu; Chu Chen
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

4.  The spectrum of disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu
Journal:  Brain       Date:  2012-12-02       Impact factor: 13.501

Review 5.  Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.

Authors:  Ann C McKee; Robert C Cantu; Christopher J Nowinski; E Tessa Hedley-Whyte; Brandon E Gavett; Andrew E Budson; Veronica E Santini; Hyo-Soon Lee; Caroline A Kubilus; Robert A Stern
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

6.  Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players.

Authors:  Philip H Montenigro; Michael L Alosco; Brett M Martin; Daniel H Daneshvar; Jesse Mez; Christine E Chaisson; Christopher J Nowinski; Rhoda Au; Ann C McKee; Robert C Cantu; Michael D McClean; Robert A Stern; Yorghos Tripodis
Journal:  J Neurotrauma       Date:  2016-06-15       Impact factor: 5.269

7.  Traumatic brain injury causes a long-lasting calcium (Ca2+)-plateau of elevated intracellular Ca levels and altered Ca2+ homeostatic mechanisms in hippocampal neurons surviving brain injury.

Authors:  David A Sun; Laxmikant S Deshpande; Sompong Sombati; Anya Baranova; Margaret S Wilson; Robert J Hamm; Robert J DeLorenzo
Journal:  Eur J Neurosci       Date:  2008-03-25       Impact factor: 3.386

8.  Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein.

Authors:  Richard Rubenstein; Binggong Chang; Natalia Grinkina; Eleanor Drummond; Peter Davies; Meir Ruditzky; Deep Sharma; Kevin Wang; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2017-04-18       Impact factor: 7.801

9.  Long-term cognitive impairments and pathological alterations in a mouse model of repetitive mild traumatic brain injury.

Authors:  Jian Luo; Andy Nguyen; Saul Villeda; Hui Zhang; Zhaoqing Ding; Derek Lindsey; Gregor Bieri; Joseph M Castellano; Gary S Beaupre; Tony Wyss-Coray
Journal:  Front Neurol       Date:  2014-02-04       Impact factor: 4.086

10.  Converging and Differential Brain Phospholipid Dysregulation in the Pathogenesis of Repetitive Mild Traumatic Brain Injury and Alzheimer's Disease.

Authors:  Joseph O Ojo; Moustafa Algamal; Paige Leary; Laila Abdullah; Benoit Mouzon; James E Evans; Michael Mullan; Fiona Crawford
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

View more
  1 in total

Review 1.  Recent Advances in the Modeling of Alzheimer's Disease.

Authors:  Hiroki Sasaguri; Shoko Hashimoto; Naoto Watamura; Kaori Sato; Risa Takamura; Kenichi Nagata; Satoshi Tsubuki; Toshio Ohshima; Atsushi Yoshiki; Kenya Sato; Wakako Kumita; Erika Sasaki; Shinobu Kitazume; Per Nilsson; Bengt Winblad; Takashi Saito; Nobuhisa Iwata; Takaomi C Saido
Journal:  Front Neurosci       Date:  2022-03-31       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.